Holly J. Meany, MD

Children's National
Washington, District of Columbia, United States

Presentation(s):

• S39 - IMPACT OF DIAGNOSTIC BIOPSY TECHNIQUE ON THE ADEQUACY OF BIOLOGIC DATA REQUIRED TO RISK-STRATIFY PATIENTS WITH NON-HIGH-RISK NEUROBLASTOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP

  Friday, May 9, 2025
  4:56 PM – 5:04 PM East Coast USA Time